Lombard Odier Asset Management (Europe)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-42,737
Closed -$17.4M 282
2022
Q4
$17.4M Buy
42,737
+7,687
+22% +$2.98M 0.71% 45
2022
Q3
$11.4M Buy
35,050
+18,586
+113% +$6.83M 0.59% 52
2022
Q2
$5.77M Buy
+16,464
New +$6.71M 0.29% 101
2020
Q4
Sell
-884
Closed -$348K 295
2020
Q3
$348K Buy
+884
New +$327K 0.02% 226
2020
Q2
Sell
-884
Closed -$214K 221
2020
Q1
$214K Hold
884
0.02% 266
2019
Q4
$231K Hold
884
0.02% 363
2019
Q3
$240K Hold
884
0.02% 338
2019
Q2
$243K Buy
+884
New +$218K 0.02% 338
2018
Q4
Sell
-884
Closed -$221K 380
2018
Q3
$221K Buy
+884
New +$215K 0.02% 359
2017
Q4
Sell
-1,319
Closed -$205K 439
2017
Q3
$205K Hold
1,319
0.01% 415
2017
Q2
$213K Hold
1,319
0.01% 392
2017
Q1
$204K Buy
+1,319
New +$182K 0.01% 377

Other funds holding IDXX

Lombard Odier Asset Management (Europe)'s IDXX Position: Q1 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 42,737 shares — an estimated $17.4M sold.

Lombard Odier Asset Management (Europe) first reported a position in IDXX in Q1 2017 and held it in 12 quarters. The position peaked at $17.4M in Q4 2022. 1,056 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 42,737 Idexx Laboratories shares in Q1 2023, an estimated $17.4M.
  • Lombard Odier Asset Management (Europe) first reported a position in Idexx Laboratories in Q1 2017 and held it in 12 quarters.
  • Lombard Odier Asset Management (Europe)'s Idexx Laboratories position peaked at $17.4M in Q4 2022.
  • 1,056 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2023, filed 15 May 2023.